• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.25% Nasdaq Up0.05%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    0.88 Up 0.02(2.33%) 3:40PM EST - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingOct 31, 2015Jul 31, 2015Apr 30, 2015Jan 31, 2015
    Total Revenue 9,523   9,671   9,308   5,677  
    Cost of Revenue4,741  4,608  4,758  3,113  
    Gross Profit 4,782   5,063   4,550   2,564  
    Operating Expenses
    Research Development14,190  13,918  11,531  11,261  
    Selling General and Administrative4,416  4,899  5,188  4,325  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (13,824) (13,754) (12,169) (13,022)
    Income from Continuing Operations
    Total Other Income/Expenses Net626  31  34  29  
    Earnings Before Interest And Taxes(13,198)(13,723)(12,135)(12,993)
    Interest Expense -   -   -  1  
    Income Before Tax(13,198)(13,723)(12,135)(12,994)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(13,198)(13,723)(12,135)(12,994)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (13,198) (13,723) (12,135) (12,994)
    Preferred Stock And Other Adjustments(1,035)(1,378)(1,119)(775)
    Net Income Applicable To Common Shares (14,233) (15,101) (13,254) (13,769)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.